Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating and Local Expression Levels of Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases

NCT04413292 is registered in ClinicalTrials.gov with South Valley University as lead sponsor.

NCT NCT04413292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04413292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating and Local Expression Levels of Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases
Lead sponsor
South Valley University
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
April 1, 2020
Enrollment
93 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial neoplasm benign